6 employees
RocketVax is a biotech company that develops novel vaccines by incorporating molecular and DNA-based technology.
2020
$3.5M
from 1 investors over 1 rounds
RocketVax raised $3.5M on August 3, 2021
Investors: Innosuisse - Schweizerische Agentur für Innovationsförderung